Welcome to our dedicated page for Wolters Kluwer N V news (Ticker: WTKWY), a resource for investors and traders seeking the latest updates and insights on Wolters Kluwer N V stock.
Wolters Kluwer N.V. (WTKWY) delivers professional information and software solutions across healthcare, legal, finance, and compliance sectors through integrated digital platforms and AI-driven tools. This page aggregates official announcements and verified news developments critical for understanding the company’s market position.
Access real-time updates on earnings reports, regulatory compliance innovations, strategic partnerships, and technology advancements. Investors and professionals benefit from organized access to press releases detailing product launches, governance updates, and operational milestones that shape industry leadership.
Key content categories include regulatory guidance updates, AI-powered solution developments, financial performance disclosures, and strategic market expansions. Each update is curated to support informed analysis of the company’s role in professional services digitalization.
Bookmark this page for streamlined tracking of Wolters Kluwer’s initiatives in legal compliance systems, healthcare information tools, and ethical AI applications. Combine regular monitoring with sector-specific analysis tools for comprehensive investment research.
Wolters Kluwer (WTKWY) has appointed Greg Samios as the new CEO of its Health division, effective June 1, 2025. Samios, who brings over 25 years of healthcare experience, succeeds Stacey Caywood, who became a Member of the Executive Board on May 15, 2025.
As Executive Vice President of the Health division's largest business units, Samios has led growth in clinical decision support products like UpToDate and Medi-Span. He spearheaded the integration of generative AI into healthcare products and strengthened partnerships with digital health companies. His previous roles include Executive VP of Legal & Regulatory U.S. at Wolters Kluwer and health-focused positions at Elsevier.
Wolters Kluwer (WTKWY) has reported its latest share buyback transactions for the period of May 22-28, 2025. The company repurchased 226,259 ordinary shares at an average price of €160.75, totaling €36.4 million. This is part of a larger €1 billion share buyback program announced on February 26, 2025.
Year-to-date, Wolters Kluwer has repurchased 2,524,854 shares for a total consideration of €392.3 million at an average price of €155.38. The company has engaged third parties to execute €350 million of buybacks between May 8 and July 28, 2025. The repurchased shares will be held as treasury shares and eventually canceled for capital reduction purposes.
Wolters Kluwer (WTKWY) has reported details of its ongoing share buyback program for the period of May 8-14, 2025. The company repurchased 225,090 ordinary shares at an average price of €157.13, totaling €35.4 million. This is part of a larger €1 billion share buyback program announced on February 26, 2025.
Year-to-date, Wolters Kluwer has repurchased 2,087,422 shares for a total consideration of €322.3 million at an average price of €154.38. The company has engaged third parties to execute €350 million of buybacks between May 8 and July 28, 2025. The repurchased shares will be held as treasury shares and eventually canceled for capital reduction purposes.
Wolters Kluwer (WTKWY) has completed a portion of its share buyback program, repurchasing 162,722 ordinary shares between April 24-May 5, 2025, for €25.1 million at an average price of €153.97 per share. This fulfills the previously announced third-party agreement to repurchase €155 million in shares from February 28 to May 5, 2025.
The repurchases are part of a larger €1 billion share buyback program announced on February 26, 2025, for the year 2025. Year-to-date, the company has repurchased 1,862,332 shares for a total of €286.9 million at an average price of €154.05. The repurchased shares will be held as treasury shares and canceled to reduce capital.
["Completion of €155 million third-party share repurchase agreement", "Strong progress on €1 billion buyback program with €286.9 million already executed", "Share cancellation will reduce share count, potentially increasing EPS"]Wolters Kluwer Legal & Regulatory has acquired Inisoft Group, a Czech software provider specializing in regulatory compliance solutions for the waste management sector. Inisoft's flagship product, Envita, helps over 3,600 customers including government agencies, municipalities, and waste management providers comply with national and local waste disposal regulations through tracking and reporting capabilities.
Founded in 1992, Inisoft's 68 employees will join Wolters Kluwer's Czech and Slovakian unit. The acquisition is expected to achieve a return on invested capital above Wolters Kluwer's 8% after-tax cost of capital within 3-5 years, with an immaterial impact on earnings.